[go: up one dir, main page]

ZA200306545B - Medicinal compositions comprising diclofenac and ornoprostil. - Google Patents

Medicinal compositions comprising diclofenac and ornoprostil.

Info

Publication number
ZA200306545B
ZA200306545B ZA200306545A ZA200306545A ZA200306545B ZA 200306545 B ZA200306545 B ZA 200306545B ZA 200306545 A ZA200306545 A ZA 200306545A ZA 200306545 A ZA200306545 A ZA 200306545A ZA 200306545 B ZA200306545 B ZA 200306545B
Authority
ZA
South Africa
Prior art keywords
ornoprostil
diclofenac
medicinal compositions
medicinal
compositions
Prior art date
Application number
ZA200306545A
Other languages
English (en)
Inventor
Yoshiki Sakai
Akio Nishiura
Nobuo Katsube
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of ZA200306545B publication Critical patent/ZA200306545B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200306545A 2001-02-22 2003-08-21 Medicinal compositions comprising diclofenac and ornoprostil. ZA200306545B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001046430 2001-02-22

Publications (1)

Publication Number Publication Date
ZA200306545B true ZA200306545B (en) 2004-11-22

Family

ID=18908056

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200306545A ZA200306545B (en) 2001-02-22 2003-08-21 Medicinal compositions comprising diclofenac and ornoprostil.

Country Status (16)

Country Link
US (1) US20040068014A1 (fr)
EP (1) EP1362588A1 (fr)
JP (1) JPWO2002066030A1 (fr)
KR (1) KR20030076692A (fr)
CN (1) CN1501798A (fr)
BR (1) BR0207446A (fr)
CA (1) CA2438241A1 (fr)
CZ (1) CZ20032256A3 (fr)
HU (1) HUP0304063A3 (fr)
IL (1) IL157451A0 (fr)
MX (1) MXPA03007487A (fr)
NO (1) NO20033709L (fr)
PL (1) PL365442A1 (fr)
RU (1) RU2003125876A (fr)
WO (1) WO2002066030A1 (fr)
ZA (1) ZA200306545B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1547587A4 (fr) * 2002-08-22 2009-04-08 Ono Pharmaceutical Co Agent utilise pour reduire les effets secondaires du diclofenac
KR101393944B1 (ko) 2006-01-24 2014-05-12 수캄포 아게 연질-젤라틴 캡슐 제형물
JP5054966B2 (ja) * 2006-12-20 2012-10-24 ロート製薬株式会社 固形製剤
BR112013003062B1 (pt) 2010-08-10 2021-11-09 R.P. Scherer Technologies, Llc Processo de fabricação de uma cápsula em gel mole estável contendo bactéria probiótica microencapsulada e cápsula obtida no referido processo
WO2014060857A1 (fr) * 2012-10-19 2014-04-24 Wockhardt Limited Compositions pharmaceutiques de diclofénac ou de sels de celui-ci
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
JP6998210B2 (ja) * 2015-09-30 2022-01-18 株式会社ダイセル 易服用性固形製剤用粒子組成物及び該粒子組成物を含む易服用性固形製剤
CN106798335A (zh) * 2017-01-10 2017-06-06 威海百合生物技术股份有限公司 中链甘油三酯的应用
US20230220387A1 (en) * 2019-12-27 2023-07-13 Kagami Inc. D-serine transport modifier and screening method thereof, and screening method of d-serine transporter protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578643A (en) * 1992-05-20 1996-11-26 Loyola University Of Chicago Protective prostaglandins for use in conjunction with chemotherapeutic agents
CA2277407A1 (fr) * 1999-07-14 2001-01-14 Bernard Charles Sherman Comprime comprenant un ains et du misoprostol

Also Published As

Publication number Publication date
JPWO2002066030A1 (ja) 2004-06-17
HUP0304063A3 (en) 2005-05-30
BR0207446A (pt) 2004-04-06
IL157451A0 (en) 2004-03-28
CN1501798A (zh) 2004-06-02
US20040068014A1 (en) 2004-04-08
RU2003125876A (ru) 2005-02-10
NO20033709L (no) 2003-10-22
EP1362588A1 (fr) 2003-11-19
MXPA03007487A (es) 2003-12-08
NO20033709D0 (no) 2003-08-20
HUP0304063A2 (hu) 2004-04-28
KR20030076692A (ko) 2003-09-26
CA2438241A1 (fr) 2002-08-29
PL365442A1 (en) 2005-01-10
CZ20032256A3 (en) 2004-03-17
WO2002066030A1 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
EP1407785A4 (fr) Compositions medicinales
EP1450824A4 (fr) Composition pharmaceutique
MXPA03007215A (es) Formulaciones farmaceuticas.
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
EP1398040A4 (fr) Composition de medicament
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
GB0129117D0 (en) Pharmaceutical composition
GB0108470D0 (en) Pharmaceutical compositions and their use
EP1408896A4 (fr) Composition pharmaceutique
ZA200306545B (en) Medicinal compositions comprising diclofenac and ornoprostil.
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (en) Pharmaceutical composition
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
GB0114746D0 (en) Medicinal composition
GB0013503D0 (en) Pharmaceutical compositions and their uses
ZA200110500B (en) Pharmaceutical composition.
HUP0400733A3 (en) New benzylaminopyrimidines, their use and pharmaceutical compositions containing them
AU2002237521A1 (en) Medicinal compositions comprising diclofenac and ornoprostil
IL157411A0 (en) Pharmaceutical composition
ZA200205556B (en) Pharmaceutical compositions and their preparation.